Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Open accessThe DOI matches its Crossref record; 621 of the 626 references it cites were found in a registry or an index.
Abstract
SUMMARY: Streptococcus pyogenes , also known as group A Streptococcus (GAS), causes mild human infections such as pharyngitis and impetigo and serious infections such as necrotizing fasciitis and streptococcal toxic shock syndrome. Furthermore, repeated GAS infections may trigger autoimmune diseases, including acute poststreptococcal glomerulonephritis, acute rheumatic fever, and rheumatic heart disease. Combined, these diseases account for over half a million deaths per year globally. Genomic and molecular analyses have now characterized a large number of GAS virulence determinants, many of which exhibit overlap and redundancy in the processes of adhesion and colonization, innate immune resistance, and the capacity to facilitate tissue barrier degradation and spread within the human host. This improved understanding of the contribution of individual virulence determinants to the disease process has led to the formulation of models of GAS disease progression, which may lead to better treatment and intervention strategies. While GAS remains sensitive to all penicillins and cephalosporins, rising resistance to other antibiotics used in disease treatment is an increasing worldwide concern. Several GAS vaccine formulations that elicit protective immunity in animal models have shown promise in nonhuman primate and early-stage human trials. The development of a safe and efficacious commercial human vaccine for the prophylaxis of GAS disease remains a high priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Upon detection of these Gram-positive pyogenic bacteria, neutrophil recruitment is critical to the resolution of infection (2).”
From Epidermal hepcidin is required for neutrophil response to bacterial infection (2019) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 621
McArthur, J. D., McKay, F. C., Ramachandran, V., Shyam, P., Cork, A. J., Sanderson‐Smith, M. L., Cole, J. N., Ringdahl, U., Sjöbring, U., Ranson, M., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-109348 · Cited by 64 · cited 3×
“Phylogenetic studies of the most divergent ska sequences have revealed two main sequence clusters (cluster types 1 and 2), with evidence of smaller subclusters observed in cluster type 2 sequences (cluster types 2a and 2b) (174, 175).”
BackgroundSelf-citationAnalysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen
Wang, H., Lottenberg, R., & Boyle, M. D. P. (1995) · Microbial Pathogenesis · doi:10.1016/s0882-4010(95)90013-6 · Cited by 64 · cited 3×
“The interaction between GAS, fibrinogen, Ska, and plasminogen confers a stable cell-associated enzymatic activity which can lyse fibrin clots despite the presence of the plasmin inhibitor 2-antiplasmin (328).”
BackgroundBarnett, T. C., Patel, A. R., & Scott, J. R. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.17.5865-5875.2004 · Cited by 64
Self-citationNew protective antigen of group A streptococci
Dale, J. B., Chiang, E. Y., Liu, S., Courtney, H. S., & Hasty, D. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5118 · Cited by 64 · cited 1×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundSmeesters, P. R., McMillan, D. J., Sriprakash, K. S., & Georgousakis, M. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.133 · Cited by 63
Self-citationHuman pathogenic streptococcal proteomics and vaccine development
Cole, J. N., Henningham, A., Gillen, C. M., Ramachandran, V., & Walker, M. J. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780048 · Cited by 63 · cited 1×
“A diverse array of GAS proteins and molecules have been assessed as vaccine candidates, including cell wall-anchored proteins, membrane-associated proteins, secreted proteins, anchorless proteins, and the group A carbohydrate molecule (2, 31).”
BackgroundSelf-citationAnalysis of a Streptococcus pyogenes Puerperal Sepsis Cluster by Use of Whole-Genome Sequencing
Zakour, N. L. B., Venturini, C., Beatson, S. A., & Walker, M. J. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00675-12 · Cited by 63
Self-citationRheumatic heart disease: mediation by complex immune events.
Guilherme, L., Kohler, K. F., & Kalil, J. E. (2011) · PubMed · Cited by 62
Courtney, H. S., Hasty, D. L., & Dale, J. B. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5097-5103.2003 · Cited by 62 · cited 1×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundWang, H., Lottenberg, R., & Boyle, M. D. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.85 · Cited by 62 · cited 1×
“Thus, plasminogen acquisition via the fibrinogen-dependent pathway results in the creation of an unregulated surface protease and an immobilized plasminogen activator (348).”
BackgroundShaw, M., Thomas, B., Smith, G. D., & Dorling, D. (1925) · Springer Publishing Company eBooks · doi:10.1001/archinte.1926.00120280143012 · Cited by 62
Caswell, C. C., Lukomska, E., Seo, N., Höök, M., & Lukomski, S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05741.x · Cited by 61 · cited 1×
“Similarly, the collagen-like protein Scl1 can also mediate epithelial cell adherence and internalization by directly binding to integrins 2 1 and 11 1 through their collagen-like domains (159, 160).”
BackgroundPenicillin-resistant and penicillin-tolerant mutants of group A Streptococci
Gutmann, L., & Tomasz, A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.1.128 · Cited by 61 · cited 1×
“Ethyl methane sulfonate mutagenesis of GAS also allowed selection of penicillin-tolerant strains, with comparatively poor growth rates (488).”
BackgroundPostól, E., de Alencar, R. E., Higa, F. T., Barros, S. F., Demarchi, L. M. M. F., Kalil, J. E., & Guilherme, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060969 · Cited by 61
Blunt Trauma as a Risk Factor for Group A Streptococcal Necrotizing Fasciitis
Nuwayhid, Z. B., Aronoff, D. M., & Mulla, Z. D. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.05.011 · Cited by 61 · cited 1×
“Blunt trauma is a major risk factor for the development of necrotizing fasciitis, presumably as a result of increased vimentin expression, which is thought to tether circulating GAS to the injured muscle (287, 288).”
BackgroundRíos-Steiner, J. L., Schenone, M., Mochalkin, I., Tulinsky, A., & Castellino, F. J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4646 · Cited by 61
Wajima, T., Murayama, S. Y., Sunaoshi, K., Nakayama, E., Sunakawa, K., & Ubukata, K. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.2008/002642-0 · Cited by 61
Binding of group B streptococcal phosphoglycerate kinase to plasminogen and actin
Boone, T. J., Burnham, C. D., & Tyrrell, G. J. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.06.005 · Cited by 60
Nasr, A. B., Herwald, H., Sjöbring, U., Renné, T., Müller‐Esterl, W., & Björck, L. (1997) · Biochemical Journal · doi:10.1042/bj3260657 · Cited by 60 · cited 1×
“Activation of these clotting factors leads to the formation of a fibrin network, the generation of the proinflammatory peptide bradykinin, vasodilation, and vascular leakage (375).”
BackgroundHamilton, S. M., Bayer, C. R., Stevens, D. L., Lieber, R. L., & Bryant, A. E. (2008) · The Journal of Infectious Diseases · doi:10.1086/593016 · Cited by 59 · cited 1×
“Blunt trauma is a major risk factor for the development of necrotizing fasciitis, presumably as a result of increased vimentin expression, which is thought to tether circulating GAS to the injured muscle (287, 288).”
BackgroundThe contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis
Reglinski, M., & Sriskandan, S. (2013) · Virulence · doi:10.4161/viru.26400 · Cited by 59 · cited 1×
“Each superantigen is specific for a distinct repertoire of V gene products and can therefore activate up to 20% of circulating naive T cells (358).”
BackgroundÅkesson, P., Moritz, L., Truedsson, M., Christensson, B., & von Pawel‐Rammingen, U. (2005) · Infection and Immunity · doi:10.1128/iai.74.1.497-503.2006 · Cited by 59 · cited 13×
“The IgG-degrading enzyme of S. pyogenes (IdeS), also known as Mac-1, Sib35, and MspA, inhibits phagocytosis, neutrophil activation, and the release of reactive oxygen species by binding Fc receptor CD16 (Fc RIIIB) on the surface of neutrophils (242, 243).”
BackgroundInfluentialLee, J. L., Naguwa, S. M., Cheema, G. S., & Gershwin, M. E. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.04.002 · Cited by 58 · cited 3×
“4 million cases in patients aged 5 to 14 years, making RHD the most common cause of pediatric heart disease worldwide (73).”
BackgroundInfluentialSmith, W. D., Pointon, J. A., Abbot, E. L., Kang, H. J., Baker, E. N., Hirst, B. H., Wilson, J. A., Banfield, M. J., & Kehoe, M. (2010) · Journal of Bacteriology · doi:10.1128/jb.00071-10 · Cited by 57 · cited 1×
“Additionally, this class B sortase also mediates the attachment of the minor pilin proteins, including the adhesin Cpa (Spy0125), which attaches to the tip of the pilus, and the basal pilin Spy0130, which acts as a linker protein for attachment to the cell wall (122, 123).”
BackgroundCrystal Structure of Spy0129, a Streptococcus pyogenes Class B Sortase Involved in Pilus Assembly
Kang, H. J., Coulibaly, F., Proft, T., & Baker, E. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015969 · Cited by 57
Musser, J. M., Stockbauer, K., Kapur, V, & Rudgers, G. W. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.1913-1917.1996 · Cited by 57 · cited 1×
“Encoded by the ubiquitous and conserved speB gene, SpeB is produced as an inactive 40-kDa zymogen and undergoes sequential N-terminal autocatalytic activation to the active 28-kDa protease (253).”
BackgroundRezcallah, M. S., Hodges, K., Gill, D. B., Atkinson, J. P., Wang, B., & Cleary, P. P. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00497.x · Cited by 56
Scavenger receptor gp340 aggregates group A streptococci by binding pili
Edwards, A. M., Manetti, A. G. O., Falugi, F., Zingaretti, C., Capo, S., Buccato, S., Bensi, G., Telford, J. L., Margarit, I., & Grandi, G. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06220.x · Cited by 56 · cited 1×
“This aggregation reduces bacterial adhesion to pharyngeal cells and therefore may serve as a bacterial clearance mechanism (130).”
BackgroundTargeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A Streptococcus Virulence
Chiarot, E., Faralla, C., Chiappini, N., Tuscano, G., Falugi, F., Gambellini, G., Taddei, A., Capo, S., Cartocci, E., Veggi, D., et al. (2013) · mBio · doi:10.1128/mbio.00387-12 · Cited by 56
Dalton, T. L., Hobb, R. I., & Scott, J. R. (2006) · Microbial Pathogenesis · doi:10.1016/j.micpath.2006.01.005 · Cited by 55 · cited 1×
“The covRS regulon directly or indirectly regulates the expression of 10 to 15% of genes in the GAS genome (294, 295, 313) and is required for GAS survival under general environmental stress conditions (309).”
BackgroundSanderson‐Smith, M. L., Walker, M. J., & Ranson, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603846200 · Cited by 55
Self-citationMonteros, L. E. E. D. L., Li, Z., Barreto, D. G., Jaimes, E. C., Rodrı́guez, R. S., Sakota, V., Facklam, R. R., & Beall, B. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.373-378.2003 · Cited by 55
Yang, P., Peng, X., Zhang, D., Wu, S., Liu, Y., Cui, S., Lu, G., Duan, W., Shi, W., Liu, S., et al. (2013) · Emerging infectious diseases · doi:10.3201/eid1906.121020 · Cited by 54 · cited 4×
“Despite these observed declines in some countries, many other countries still have exceptionally high levels of macrolide-resistant GAS strains; for example, 96% of GAS strains isolated from Beijing, China, in 2011 were erythromycin resistant (111).”
BackgroundResultInfluentialLiu, X., Shen, X., Chang, H., Huang, G., Fu, Z., Zheng, Y., Wang, L., Li, C., Liu, L., Shen, Y., et al. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.20976 · Cited by 54
Dougherty, B. A., & Rijn, I. V. D. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.5.1291 · Cited by 54 · cited 1×
“hasABC synthase operon (193, 194), the capsule is a high-molecFIG 1 The arsenal of virulence factors expressed by GAS to thwart the host innate immune response.”
BackgroundHassell, M., Fagan, P. K., Carson, P. J., & Currie, B. J. (2004) · BMC Infectious Diseases · doi:10.1186/1471-2334-4-60 · Cited by 53
Margarit, I., Bonacci, S., Pietrocola, G., Rindi, S., Ghezzo, C., Bombaci, M., Nardi‐Dei, V., Grifantini, R., Speziale, P., & Grandi, G. (2009) · The FASEB Journal · doi:10.1096/fj.09-131458 · Cited by 53 · cited 1×
“For GAS strains that do not possess high-affinity plasminogen binding proteins but do express fibrinogen binding proteins such as PrtF1 and PrtF2 variants (349), M protein variants (141), and the lipoprotein Spy0591 (350), this mechanism of plasmin acquisition may be central to plasminogen-mediated virulence.”
BackgroundFae, K. C., Palácios, S. A., Nogueira, L., Oshiro, S. E., Demarchi, L. M. M. F., Bilate, A. M. B., Pomerantzeff, P. M. A., Brandão, C. M. D. A., Thomaz, P. G., dos Reis, M., et al. (2013) · Inflammation · doi:10.1007/s10753-013-9606-2 · Cited by 53 · cited 1×
“An array of chemokines is expressed in myocardium and valvular tissue lesions, among which CXCL9/Mig was shown to play a role in mediating T-cell recruitment to the site of inflammation in the heart (394).”
BackgroundLiu, M., Zhu, H. F., Zhang, J., & Lei, B. (2007) · Infection and Immunity · doi:10.1128/iai.00038-07 · Cited by 53 · cited 1×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundProspective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007
Steer, A. C., Jenney, A., Kado, J. H., Good, M. F., Batzloff, M. R., Waqatakirewa, L., Mullholland, E. K., & Carapetis, J. R. (2009) · Emerging infectious diseases · doi:10.3201/eid1502.080558 · Cited by 53
Distinguishing PANDAS from Sydenham's chorea: case report and review of the literature
van Toorn, R., Weyers, H., & Schoeman, J. F. (2004) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2004.03.005 · Cited by 53
Invasive group A streptococcal disease
Varughese, J. A., Katre, M., Rai, B., & Mallick, D. (2024) · BMJ Case Reports · doi:10.1136/bcr-2023-254646 · Cited by 53
Maddocks, S. E., Wright, C. J., Nobbs, A. H., Brittan, J. L., Franklin, L., Strömberg, N., Kadioglu, A., Jepson, M. A., & Jenkinson, H. F. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07749.x · Cited by 52
Vlaminckx, B. J. M., van Pelt, W., Schouls, L. M., van Silfhout, A., Elzenaar, C. P., Mascini, E. M., Verhoef, J., & Schellekens, J. F. P. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1147-z · Cited by 52 · cited 1×
“Examples include the association of emm types 1, 3, and 49 with invasive disease and emm types 2, 4, 6, 12, and 44/61 with superficial disease (46, 58, 59).”
BackgroundNephritogenic and Rheumatogenic Group A Streptococci
Stollerman, G. H. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/120.2.258 · Cited by 52 · cited 1×
“Furthermore, despite several excellent correlations between outbreaks of APSGN and community-wide spread of specific GAS types (417), the identity of nephritogenic components in GAS are still undefined.”
BackgroundNasr, A. B., Wistedt, A. C., Ringdahl, U., & Sjöbring, U. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18865.x · Cited by 51 · cited 1×
“Approximately 15% of GAS isolates express plasminogen binding M proteins (PAM/Prp), and similar proteins have been identified in other streptococcal species (319, 336).”
BackgroundA novel, anchorless streptococcal surface protein that binds to human immunoglobulins
Kawabata, S., Tamura, Y., Murakami, J., Terao, Y., Nakagawa, I., & Hamada, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02078-8 · Cited by 51 · cited 1×
“pyogenes (IdeS), also known as Mac-1, Sib35, and MspA, inhibits phagocytosis, neutrophil activation, and the release of reactive oxygen species by binding Fc receptor CD16 (Fc RIIIB) on the surface of neutrophils (242, 243).”
BackgroundChen, M., Yao, W., Wang, X., Li, Y., Chen, M., Wang, G., Zhang, X., Pan, H., Hu, J., & Zeng, M. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31825874f3 · Cited by 51
Pandey, M., Wykes, M., Hartas, J., Good, M. F., & Batzloff, M. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202333 · Cited by 51
Epidemic of Group AStreptococcusM/emm59 Causing Invasive Disease in Canada
Tyrrell, G. J., Lovgren, M., Jean, T. S., Hoang, L., Patrick, D. M., Horsman, G. B., Caeseele, P. G. V., Sieswerda, L. E., McGeer, A., Laurence, R. A., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/657068 · Cited by 51 · cited 1×
“An emm 59 GAS outbreak of invasive disease in North America beginning in 2004 has been reported (21, 108).”
BackgroundHigh Diversity of Group A Streptococcal emm Types among Healthy Schoolchildren in Ethiopia
Abdissa, A., Asrat, D., Kronvall, G., Shittu, B. O., Achiko, D., Zeidan, M., Yamuah, L. K., & Aseffa, A. (2006) · Clinical Infectious Diseases · doi:10.1086/503422 · Cited by 50
Wasserzug, O., Valinsky, L., Klement, E., Bar‐Zeev, Y., Davidovitch, N., Orr, N., Korenman, Z., Kayouf, R., Sela, T., Ambar, R., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597770 · Cited by 50 · cited 1×
“Examples include outbreaks in military training centers as a result of crowding (93, 94), multiple outbreaks following consumption of contaminated foods (95–102), and hospital-acquired puerperal sepsis outbreaks (22–24).”
BackgroundMolecular Analysis of an Outbreak of Lethal Postpartum Sepsis Caused by Streptococcus pyogenes
Turner, C. E., Dryden, M., Holden, M. T. G., Davies, F., Lawrenson, R. A., Farzaneh, L., Bentley, S. D., Efstratiou, A., & Sriskandan, S. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00679-13 · Cited by 50
Hoe, N. P., Vuopio‐Varkila, J., Vaara, M., Grigsby, D., Lorenzo, D., Fu, Y., Dou, S., Pan, X., Nakashima, K., & Musser, J. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/318543 · Cited by 50 · cited 1×
“The sic gene is highly polymorphic, suggesting that it is under strong immune selective pressure to avoid host neutralizing antibodies (55).”
BackgroundStudy of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence
Sjögren, J., Okumura, C. Y. M., Collin, M., Nizet, V., & Hollands, A. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-120 · Cited by 50 · cited 1×
“The heterologous expression of EndoS in strains of non-M1 serotypes enhances virulence in a mouse model of invasive GAS infection (249).”
BackgroundSelf-citationGryllos, I., Cywes‐Bentley, C., Shearer, M. H., Cary, M. E., Kennedy, R. C., & Wessels, M. R. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02635.x · Cited by 50 · cited 1×
“pression is upregulated in human blood (190, 191), and hyperen-”
BackgroundOehmcke-Hecht, S., Shannon, O., von Köckritz‐Blickwede, M., Mörgelin, M., Linder, A., Olin, A. I., Björck, L., & Herwald, H. (2009) · Blood · doi:10.1182/blood-2008-10-182527 · Cited by 49
A Bacterial Pathogen Co-opts Host Plasmin to Resist Killing by Cathelicidin Antimicrobial Peptides
Hollands, A., Gonzalez, D., Leire, E., Donald, C., Gallo, R. L., Sanderson-Smith, M., Dorrestein, P. C., & Nizet, V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.404582 · Cited by 49 · cited 8×
“The expression of the M protein and hyaluronic acid cap- April 2014 Volume 27 Number 2 cmr.asm.org 273 sule enhances GAS survival within NETs by increasing bacterial resistance to the antimicrobial peptide LL-37 (201).”
BackgroundInfluentialSelf-citationGroup A Streptococcal Vaccine Candidates: Potential for the Development of a Human Vaccine
Henningham, A., Gillen, C. M., & Walker, M. J. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_284 · Cited by 48 · cited 1×
“A diverse array of GAS proteins and molecules have been assessed as vaccine candidates, including cell wall-anchored proteins, membrane-associated proteins, secreted proteins, anchorless proteins, and the group A carbohydrate molecule (2, 31).”
BackgroundSelf-citationSriskandan, S., Unnikrishnan, M., Krausz, T. N., & Cohen, J. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01525.x · Cited by 48 · cited 1×
“Early studies of STSS in which GAS serotypes M1 and M3 were associated significantly with infection suggested that there may be an association between the superantigen gene repertoire and invasive GAS disease (365–367); however, targeted mutagenesis of SpeA has a limited effect on the mitogenic activity of toxigenic G…”
Påhlman, L. I., Marx, P. F., Mörgelin, M., Łukomski, S., Meijers, J. C. M., & Herwald, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610015200 · Cited by 48
Serious Group A Streptococcal Infections
Wong, C. J., & Stevens, D. L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.03.003 · Cited by 47 · cited 1×
“Initial management of severe invasive GAS infection includes hemodynamic stabilization and specific antimicrobial therapy (455).”
BackgroundHartas, J., & Sriprakash, K. S. (1999) · Microbial Pathogenesis · doi:10.1006/mpat.1998.0244 · Cited by 47
Self-citationGiovanetti, E., Brenciani, A., Tiberi, E., Bacciaglia, A., & Varaldo, P. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05352-11 · Cited by 47
Inactivation of DltA Modulates Virulence Factor Expression in Streptococcus pyogenes
Cox, K. H., Ruíz-Bustos, E., Courtney, H. S., Dale, J. B., Pence, M. A., Nizet, V., Aziz, R. K., Gerling, I., Price, S. M., & Hasty, D. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005366 · Cited by 47 · cited 1×
“deposition and killing in whole human blood (265).”
BackgroundSelf-citationAcute rheumatic fever and poststreptococcal reactive arthritis reconsidered
Mil, A. H. M. V. D. H. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328337ba26 · Cited by 46
Diagnosis and Treatment of Streptococcal Pharyngitis
SOMAN, M. P. (1985) · JAMA · doi:10.1001/jama.1985.03360070045006 · Cited by 46
Divergence in the Plasminogen-binding Group A Streptococcal M Protein Family
Sanderson‐Smith, M. L., Batzloff, M. R., Sriprakash, K. S., Dowton, M., Ranson, M., & Walker, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508758200 · Cited by 46
Self-citationOehmcke-Hecht, S., Westman, J., Malmström, J. A., Mörgelin, M., Olin, A. I., Kreikemeyer, B., & Herwald, H. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003529 · Cited by 46 · cited 1×
“The level of procoagulant microvesicles increases significantly in a mouse model of invasive streptococcal infection, and these microvesicles appear to bind to the streptococcal surface, leading to the entrapment of the bacteria within a dense fibrin network (386).”
BackgroundMelo‐Cristino, J., Fernandes, M. L., & PORTUGUESE SURVEILLANCE GROUP FOR THE STUDY OF RESPIRATORY PATHOGENS (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.219 · Cited by 46
Katerov, V., Andreev, A., Schalén, C., & Totolian, A. A. (1998) · Microbiology · doi:10.1099/00221287-144-1-119 · Cited by 46
Kaplan, E. L., Couser, R. J., Huwe, B., Mckay, C., & Wannamaker, L. W. (1979) · PEDIATRICS · doi:10.1542/peds.64.6.904 · Cited by 45
Oehmcke-Hecht, S., Mörgelin, M., Malmström, J. A., Linder, A., Chew, M. S., Thorlacius, H., & Herwald, H. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01705.x · Cited by 45
High burden of invasive β-haemolytic streptococcal infections in Fiji
STEER, A. C., JENNEY, A. J. W., OPPEDISANO, F., BATZLOFF, M. R., HARTAS, J., PASSMORE, J., RUSSELL, F. M., KADO, J. H. H., & CARAPETIS, J. R. (2008) · Epidemiology and Infection · doi:10.1017/s095026880700917x · Cited by 45 · cited 1×
“6 per 100,000 [91, 92]).”
Linkage of T3 and Cpa pilins in the Streptococcus pyogenes M3 pilus
Quigley, B. R., Zähner, D., Hatkoff, M., Thanassi, D. G., & Scott, J. R. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06727.x · Cited by 45 · cited 1×
“Additionally, this class B sortase also mediates the attachment of the minor pilin proteins, including the adhesin Cpa (Spy0125), which attaches to the tip of the pilus, and the basal pilin Spy0130, which acts as a linker protein for attachment to the cell wall (122, 123).”
BackgroundParameters Governing Invasive Disease Propensity of Non-M1 Serotype Group A Streptococci
Maamary, P. G., Sanderson‐Smith, M. L., Aziz, R. K., Hollands, A., Cole, J. N., McKay, F. C., McArthur, J. D., Kirk, J. K., Cork, A. J., Keefe, R. J., et al. (2010) · Journal of Innate Immunity · doi:10.1159/000317640 · Cited by 45 · cited 3×
“The frequency of covRS mutations in strains of non-M1T1 GAS serotypes is lower than that in M1T1 strains, which may explain why strains of non-M1 serotypes are less frequently isolated from human invasive infections (314).”
BackgroundSelf-citationInvasive Group A Streptococcal Disease
Mascini, E. M., Hazenberg, M. M. J., van Dalen, A., Verhoef‐Verhage, L. A. E., van Leeuwen, N. J., Verhoef, J., & van Dijk, H. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1825-3_215 · Cited by 45
Scarlet fever outbreak in Hong Kong, 2011
Hsieh, Y., & Huang, Y. (2011) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2011.07.003 · Cited by 44
Species specificity of streptokinase
Marcum, J. A., & Kline, D. L. (1983) · Comparative Biochemistry and Physiology Part B Comparative Biochemistry · doi:10.1016/0305-0491(83)90345-0 · Cited by 44 · cited 1×
“GAS secretes the plasminogen activator streptokinase (Ska), which is highly specific for human plasminogen (332).”
BackgroundDinkla, K., Sastalla, I., Godehardt, A. W., Janze, N., Chhatwal, G. S., Rohde, M., & Medina, E. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.03.011 · Cited by 44 · cited 1×
“The GAS capsule blocks antibody access to surface epitopes (200), inhibits complement deposition (188), promotes resistance to opsonophagocytosis (188, 189), enhances survival within neutrophil extracellular traps (NETs) (201), and is necessary for full virulence in mouse (202–205) and nonhuman primate (206) models of…”
BackgroundHasenbein, M. E., Warner, J. E., Lambert, K. G., Cole, S., Onderdonk, A. B., & McAdam, A. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1559-1563.2004 · Cited by 44
Localization of the streptococcal C5a peptidase to the surface of group A streptococci
O'Connor, S. P., & Cleary, P. P. (1986) · Infection and Immunity · doi:10.1128/iai.53.2.432-434.1986 · Cited by 44
The Reemergence of Severe Group A Streptococcal Disease: an Evolutionary Perspective
Low, D. E., Schwartz, B., & McGeer, A. (2014) · ASM Press eBooks · doi:10.1128/9781555816940.ch7 · Cited by 43 · cited 1×
“There has been a notable global increase in the percentage of invasive GAS infections that are severe since the late 1980s (19, 20, 83, 84).”
BackgroundPlatelets promote bacterial dissemination in a mouse model of streptococcal sepsis
Kahn, F., Hurley, S. M., & Shannon, O. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.05.003 · Cited by 43 · cited 3×
“It was hypothesized that GAS may utilize platelet binding to facilitate passage through the blood to other organs or that bacteria in complex with platelets may be protected from the host immune response (384).”
BackgroundPlasmin(ogen) Acquisition by Group A Streptococcus Protects against C3b-Mediated Neutrophil Killing
Ly, D., Taylor, J. M., Tsatsaronis, J. A., Monteleone, M. M., Skora, A. S., Donald, C. A., Maddocks, T. A., Nizet, V., West, N. P., Ranson, M., et al. (2013) · Journal of Innate Immunity · doi:10.1159/000353754 · Cited by 43
Self-citationRavins, M., Jaffe, J., Hanski, E., Shetzigovski, I., Natanson‐Yaron, S., & Moses, A. E. (2000) · The Journal of Infectious Diseases · doi:10.1086/317635 · Cited by 43 · cited 1×
“pression is upregulated in human blood (190, 191), and hyperen-”
BackgroundHoe, N. P., Kordari, P., Cole, R. L., Liu, M., Palzkill, T. G., Huang, W., McLellan, D. G. J., Adams, G. J., Hu, M. C., Vuopio‐Varkila, J., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315882 · Cited by 42
Courtney, H. S., Liu, S., Dale, J. B., & Hasty, D. L. (1997) · Infection and Immunity · doi:10.1128/iai.65.6.2472-2474.1997 · Cited by 42
Liang, Y., Liu, X., Chang, H., Ji, L., Huang, G., Fu, Z., Zheng, Y., Wang, L., Li, C., Shen, Y., et al. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.042309-0 · Cited by 42
Invasive Group a Streptococcal Disease
Weston, D. (2008) · doi:10.1002/9780470988091.ch12 · Cited by 41
Tonsillopharyngitis Caused by Foodborne Group A Streptococcus: A Prison‐Based Outbreak
Levy, M. Z., Johnson, C. G., & Kraa, E. (2003) · Clinical Infectious Diseases · doi:10.1086/345670 · Cited by 41
Assembly Mechanism of FCT Region Type 1 Pili in Serotype M6 Streptococcus pyogenes
Nakata, M., Kimura, K. R., Sumitomo, T., Wada, S., Sugauchi, A., Oiki, E., Higashino, M., Kreikemeyer, B., Podbielski, A., Okahashi, N., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.239780 · Cited by 40 · cited 1×
“Sortase A is responsible for linking the pilus structure to the cell wall (124).”
BackgroundTherapies for necrotising fasciitis
Young, M. H., Engleberg, N. C., Mulla, Z. D., & Aronoff, D. M. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.2.155 · Cited by 40 · cited 1×
“When necrotizing fasciitis is suspected, prompt surgical exploration is required, and debridement or fasciotomy is almost always necessary (456).”
BackgroundFailure of Once-Daily Penicillin V Therapy for Streptococcal Pharyngitis
Gerber, M. A. (1989) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1989.02150140039016 · Cited by 40 · cited 1×
“Oral penicillin must be administered 2 to 4 times a day for 10 days in order to achieve maximal rates of GAS eradication (445).”
BackgroundGroup A streptococcal pharyngitis and immune-mediated complications: from diagnosis to management
Shulman, S. T., & Tanz, R. R. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.134 · Cited by 40 · cited 1×
“APSGN is an immune complex-mediated disorder of the kidneys, resulting in symptoms such as edema, hypertension, urinary sediment abnormalities, and decreased levels of complement components in the serum (66, 75).”
BackgroundFagan, P. K., Reinscheid, D., Gottschalk, B., & Chhatwal, G. S. (2001) · Infection and Immunity · doi:10.1128/iai.69.8.4851-4857.2001 · Cited by 40
Rodríguez-Avial, I., Rodríguez-Avial, C., Culebras, E., & Picazo, J. J. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00062-1 · Cited by 39 · cited 1×
“Efflux pumps for tetracycline encoded by the tet(K) or tet(L) gene also confer tetracycline resistance; however, in contrast to macrolide resistance, these efflux pumps are relatively uncommon in streptococci (512, 513).”
BackgroundInvasive group A streptococcal disease in children in Queensland
Whitehead, B., Smith, H. V., & Nourse, C. B. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810001378 · Cited by 39 · cited 1×
“5 per 100,000 [87–89]), Africa (13.”
Pletz, M. W., McGee, L., Beneden, C. V., Petit, S., Bardsley, M., Barlow, M., & Klugman, K. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.943-948.2006 · Cited by 38 · cited 1×
“These point mutations may be acquired by spontaneous mutation within the QRDR or via horizontal gene transfer (527).”
BackgroundKumar, R., Vohra, H., Chakraborty, A., Sharma, Y. P., Bandhopadhya, S., Dhanda, V., Sagar, V., Sharma, M., Shah, B., & Ganguly, N. K. (2009) · PubMed · Cited by 38
Delvecchio, A., Currie, B. J., McArthur, J. D., Walker, M. J., & Sriprakash, K. S. (2002) · Epidemiology and Infection · doi:10.1017/s0950268802006787 · Cited by 38 · cited 4×
“For GAS strains that do not possess high-affinity plasminogen binding proteins but do express fibrinogen binding proteins such as PrtF1 and PrtF2 variants (349), M protein variants (141), and the lipoprotein Spy0591 (350), this mechanism of plasmin acquisition may be central to plasminogen-mediated virulence.”
BackgroundInfluentialSelf-citationIkebe, T., Hirasawa, K., Suzuki, R., Isobe, J., Tanaka, D., Katsukawa, C., Kawahara, R., Tomita, M., Ogata, K., Endoh, M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.788-790.2005 · Cited by 38
McArthur, J. D., Medina, E., Müeller, A., Chin, J. J.-C., Currie, B. J., Sriprakash, K. S., Talay, S. R., Chhatwal, G. S., & Walker, M. J. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7342-7345.2004 · Cited by 38 · cited 1×
“For example, protein F1/SfbI was observed to protect against GAS intranasal challenge (240) but did not protect against subcutaneous challenge (580).”
BackgroundSelf-citationRheumatic fever and poststreptococcal reactive arthritis
Gibofsky, A., & Zabriskie, J. B. (1995) · Current Opinion in Rheumatology · doi:10.1097/00002281-199507000-00006 · Cited by 37 · cited 41×
“In a 2005 study, the highest rates of ARF were found in sub-Saharan Africa (5.7 cases per 1,000), in the Pacific Islander and indigenous minority populations of Australia and New Zealand (3.5 cases per 1,000), and south central Asia (United Nations regional classification) (2.2 cases per 1,000) (5).”
BackgroundInfluentialAnti-inflammatory treatment for carditis in acute rheumatic fever
Cilliers, A. M., Manyemba, J., Adler, A. J., & Saloojee, H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003176.pub2 · Cited by 37
Montes, M., Tamayo, E. H., Orden, B., Larruskain, J., & Pérez‐Trallero, E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00780-09 · Cited by 36 · cited 2×
“High-level resistance results from additional point mutations in the DNA gyrase (gyrA and gyrB) genes (521).”
BackgroundThe fall and rise of rheumatic fever in the United States: a commentary
Kaplan, E. L., & Markowitz, M. (1988) · International Journal of Cardiology · doi:10.1016/0167-5273(88)90003-4 · Cited by 36
Cross‐Protection between Group A and Group B Streptococci Due to Cross‐Reacting Surface Proteins
Stålhammar‐Carlemalm, M., Areschoug, T., Larsson, C., & Lindahl, G. (2000) · The Journal of Infectious Diseases · doi:10.1086/315693 · Cited by 36 · cited 1×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundFluoroquinolone Resistance inStreptococcus pyogenes
Richter, S. S., Diekema, D. J., Heilmann, K. P., Almer, L. S., Shortridge, V. D., Zeitler, R., Flamm, R. K., & Doern, G. V. (2003) · Clinical Infectious Diseases · doi:10.1086/345904 · Cited by 36
Reactive arthritis associated with group C and group G beta-hemolytic streptococci.
Jansen, T., Janssen, M., & de Jong, A. J. L. (1998) · PubMed · Cited by 36
Is streptolysin S of group A streptococci a virulence factor?
Ginsburg, I. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01509.x · Cited by 35 · cited 2×
“Furthermore, the synergistic interaction between SLS, SpeB, and neutrophil-derived proteases has been shown to produce cellular injury in vitro (234).”
BackgroundLinder, A., Johansson, L., Thulin, P., Hertzén, E., Mörgelin, M., Christensson, B., Björck, L., Norrby‐Teglund, A., & Åkesson, P. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.437 · Cited by 35
Ayer, V., Tewodros, W., Manoharan, A., Skariah, S., Luo, F. H., & Bessen, D. E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01341-06 · Cited by 35 · cited 1×
“In a cohort of GAS strains sampled globally between 1990 and 2000, 38% and 25% displayed resistance to tetracycline and erythromycin, respectively, and 15% of isolates were resistant to both classes of drugs (514).”
BackgroundStjernquist‐Desatnik, A., Samuelsson, P., & Walder, M. (1993) · The Journal of Laryngology & Otology · doi:10.1017/s0022215100122893 · Cited by 34
Scarlet Fever Outbreak, Hong Kong, 2011
Lau, E. H. Y., Nishiura, H., Cowling, B. J., Ip, D., & Wu, J. T. K. (2012) · Emerging infectious diseases · doi:10.3201/eid1810.120062 · Cited by 34
New approaches to the treatment of group A streptococcal pharyngitis
Gerber, M. A., & Tanz, R. R. (2001) · Current Opinion in Pediatrics · doi:10.1097/00008480-200102000-00009 · Cited by 33 · cited 1×
“Also, such antibiotic alternatives tend to be more expensive than standard therapy and, with broader spectra of activity than penicillin, may produce greater perturbations to the normal flora (450).”
BackgroundBeachey, E. H., Gras‐Masse, H., Tarter, A., Jolivet, M., Audibert, F., CHEDID, L. A., & Seyer, J. M. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.6.1451 · Cited by 33
Baker, M. D., Gutman, D. M., Papageorgiou, A. C., Collins, C. M., & Acharya, K. R. (2001) · Protein Science · doi:10.1110/ps.330101 · Cited by 33
Silva‐Costa, C., Ramirez, M., & Melo‐Cristino, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2109-2111.2005 · Cited by 33
Ikebe, T., HIRASAWA, K., SUZUKI, R., Ohya, H., Isobe, J., Tanaka, D., Katsukawa, C., Kawahara, R., Tomita, M., Ogata, K., et al. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807007984 · Cited by 32
Okumura, C. Y. M., Anderson, E. L., Döhrmann, S., Tran, D. N., Olson, J., von Pawel‐Rammingen, U., & Nizet, V. (2013) · mBio · doi:10.1128/mbio.00499-13 · Cited by 32 · cited 1×
“However, isogenic mutant studies found that IdeS is not essential for phagocyte resistance or mouse virulence in serotype M1T1 GAS strains (245).”
BackgroundSelf-citationA Novel Plasminogen/Plasmin Binding Protein on the Surface of Group A Streptococci
Pancholi, V., & Fischetti, V. A. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1825-3_138 · Cited by 32 · cited 1×
“In addition to specialized plasminogen receptors, GAS bacteria secrete the glycolytic pathway enzymes -enolase/SEN (343) and GAPDH/Plr/SDH (152), which themselves display plasminogen binding abilities.”
BackgroundGerber, M. A. (1996) · PEDIATRICS · doi:10.1542/peds.97.6.971 · Cited by 31 · cited 1×
“Penicillin resistance has not occurred in GAS anywhere in the world (440), and the baseline level of macrolide resistance is approximately 5 to 10%, although significant outbreaks of macrolide-resistant strains have appeared in specific communities (441– 444), such that clinicians should be aware of local resistance p…”
BackgroundBauer, M. J., Georgousakis, M., Vu, T., Henningham, A., Hofmann, A., Rettel, M., Hafner, L. M., Sriprakash, K. S., & McMillan, D. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.115 · Cited by 31
Self-citationRaymond, J., Schlegel, L., Garnier, F., & Bouvet, A. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502567 · Cited by 31
Structure of streptococcal pyrogenic exotoxin A reveals a novel metal cluster
Earhart, C. A., Vath, G. M., Roggiani, M., Schlievert, P. M., & Ohlendorf, D. H. (2000) · Protein Science · doi:10.1110/ps.9.9.1847 · Cited by 31
STUDIES ON THE PATHOGENICITY OF GROUP A STREPTOCOCCI
Foley, M. J., Smith, M. R., & Wood, W. B. (1959) · The Journal of Experimental Medicine · doi:10.1084/jem.110.4.603 · Cited by 30 · cited 2×
“The GAS capsule blocks antibody access to surface epitopes (200), inhibits complement deposition (188), promotes resistance to opsonophagocytosis (188, 189), enhances survival within neutrophil extracellular traps (NETs) (201), and is necessary for full virulence in mouse (202–205) and nonhuman primate (206) models of…”
BackgroundPhysiological properties of penicillin-binding proteins in group A streptococci
Gutmann, L., Williamson, R., & Tomasz, A. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.5.872 · Cited by 30 · cited 3×
“A mouse model of streptococcal myositis indicated that clindamycin can be more effective than penicillin in eradicating GAS in severe, invasive infections; in part, this may result from the “Eagle effect,” wherein GAS reduces the expression of penicillin binding proteins (PBPs) during the stationary growth phase (459).”
BackgroundD'Costa, S. S., & Boyle, M. D. P. (1998) · Microbial Pathogenesis · doi:10.1006/mpat.1998.0207 · Cited by 30
Binks, M., & Sriprakash, K. S. (2004) · Infection and Immunity · doi:10.1128/iai.72.7.3981-3986.2004 · Cited by 30 · cited 1×
“Variants of SIC, termed CRS (closely related to SIC) and DRS (distantly related to SIC), also bind complement proteins C6 and C7 (216, 217).”
BackgroundSelf-citationMacrolide Prescriptions and Erythromycin Resistance of Streptococcus pyogenes
Gagliotti, C., Nobilio, L., Milandri, M., Moro, M. L., & Emilia-Romagna Antibiotic Resistance Study Group (2006) · Clinical Infectious Diseases · doi:10.1086/501460 · Cited by 30
Okamoto, S., Tamura, Y., Terao, Y., Hamada, S., & Kawabata, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.02.035 · Cited by 29
Farmand, S., Henneke, P., Hufnagel, M., & Berner, R. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1362-3 · Cited by 29 · cited 1×
“6% (505); in Belgium, the prevalence fell from 13.”
BackgroundSyrogiannopoulos, G. A., Bozdoğan, B., Grivea, I. N., Ednie, L. M., Kritikou, D., Katopodis, G. D., Beratis, N. G., & Appelbaum, P. C. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000138080.74674.a2 · Cited by 29 · cited 1×
“Several antimicrobial agents, including clarithromycin, cefuroxime, and cefixime, can successfully eradicate GAS from the pharynx when administered for 5 days (446, 447), and effective eradication with once-daily dosing has been described for amoxicillin, azithromycin, and various cephalosporins (448, 449).”
BackgroundThe AgI/II Family Adhesin AspA Is Required for Respiratory Infection by Streptococcus pyogenes
Franklin, L., Nobbs, A. H., Bricio-Moreno, L., Wright, C. J., Maddocks, S. E., Sahota, J. S., Ralph, J., O’Connor, M., Jenkinson, H. F., & Kadioglu, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062433 · Cited by 29
Skin infections among Indigenous Australians in an urban setting in Far North Queensland
Valery, P. C., Wenitong, M., Clements, V., Sheel, M., McMillan, D. J., Stirling, J., Sriprakash, K. S., Batzloff, M. R., Vohra, R., & McCarthy, J. S. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807009740 · Cited by 29 · cited 1×
“The disease is spread through direct skin contact and most commonly affects children living in tropical and subtropical climates in areas with poor hygiene and crowded living conditions (69, 70).”
BackgroundSelf-citationde Melo, M. C. N., Figueiredo, A. M. S., & Ferreira‐Carvalho, B. T. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.04938-0 · Cited by 29
Genomic Analysis ofemm59Group AStreptococcusInvasive Strains, United States
Fittipaldi, N., Olsen, R. J., Beres, S. B., Beneden, C. V., & Musser, J. M. (2012) · Emerging infectious diseases · doi:10.3201/eid1804.111803 · Cited by 29 · cited 1×
“An emm 59 GAS outbreak of invasive disease in North America beginning in 2004 has been reported (21, 108).”
BackgroundYoshizawa, N. (2000) · Internal Medicine · doi:10.2169/internalmedicine.39.687 · Cited by 29 · cited 1×
“However, the pathogenic mechanism of APSGN remains incompletely understood (416).”
BackgroundGillen, C. M., Courtney, H. S., Schulze, K., Rohde, M., Wilson, M. R., Timmer, A. M., Guzmán, C. A., Nizet, V., Chhatwal, G. S., & Walker, M. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706739200 · Cited by 28 · cited 8×
“The incorporation of the active forms of these antigens into GAS vaccine preparations may raise safety concerns, and consequently, inactive forms of these antigens have been engineered by employing site-directed mutagenesis for use in vaccine studies, including SOF (581), ScpA (571), SpeB (575), SpyCEP (578, 582), SLO…”
BackgroundInfluentialSelf-citationSriprakash, K. S., Hartas, J., & White, A. A. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-7-589 · Cited by 28 · cited 3×
“Four of the major nephritis-associated GAS serotypes (serotypes M1, M12, M55, and M57) produce highly antigenic secretory proteins called streptococcal inhibitor of complement (SIC) and distantly related to SIC (DRS).”
BackgroundSelf-citationOgawa, T., Terao, Y., Sakata, H., Okuni, H., Ninomiya, K., Ikebe, K., Maeda, Y., & Kawabata, S. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02252.x · Cited by 27 · cited 1×
“There has been only a single report of naturally occurring penicillin-tolerant GAS (472); however, this report has not been independently confirmed.”
Poststreptococcal Reactive Arthritis in Adults: Long-Term Follow-Up
Gamarra, A. I., Jimenez, C. A., Cañas, C. A., Restrepo, J. D. L., Peña, M., Valle, R., Mendez, E. A., Leon, J. H. P. D., Espinoza, L. R., & Cuellar, M. L. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200103000-00003 · Cited by 27 · cited 1×
“Unlike ARF, poststreptococcal reactive arthritis is rarely associated with carditis; a longterm follow-up study (412) did not reveal cardiac involvement in poststreptococcal reactive arthritis patients.”
BackgroundHuang, Y.-S., Fisher, M., Nasrawi, Z., & Eichenbaum, Z. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir149 · Cited by 27 · cited 1×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundKallikrein-Kinin System Activation in Streptococcal Toxic Shock Syndrome
Sriskandan, S., & Cohen, J. (2000) · Clinical Infectious Diseases · doi:10.1086/313827 · Cited by 26
Skattum, L., Åkesson, P., Truedsson, L., & Sjöholm, A. G. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000091745 · Cited by 26 · cited 1×
“A similar study showed an association between APSGN and SIC seropositivity in a Swedish pediatric population (432).”
BackgroundUptake and Intracellular Trafficking of Superantigens in Dendritic Cells
Ganem, M. B., Marzi, M. C. D., Fernández-Lynch, M. J., Jancic, C. C., Vermeulen, M. E., Geffner, J. R., Mariuzza, R. A., Fernández, M. M., & Malchiodi, E. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066244 · Cited by 26 · cited 1×
“Rampant T-cell activation has also been shown to occur following the uptake of superantigens by dendritic cells in vivo, further contributing to the proinflammatory cascade (359).”
BackgroundStreptococcus pyogenes bacteraemia, emm types and superantigen profiles
Rantala, S., Vähäkuopus, S., Siljander, T., Vuopio, J., Huhtala, H., Vuento, R., & Syrjänen, J. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1385-9 · Cited by 26
A Key Role for the Urokinase Plasminogen Activator (uPA) in Invasive Group A Streptococcal Infection
Sanderson‐Smith, M. L., Zhang, Y., Ly, D., Donahue, D. L., Hollands, A., Nizet, V., Ranson, M., Ploplis, V. A., Walker, M. J., & Castellino, F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003469 · Cited by 26 · cited 1×
“In addition, it has recently been demonstrated that serotype M1T1 GAS strains utilize the host activator uPA to acquire cell surface plasmin in the absence of Ska and that this interaction also plays a role in a mouse model of invasive GAS disease (335).”
BackgroundSelf-citationShaila, M. S., Nayak, R., Prakash, S. S., Georgousakis, M., Brandt, E. R., McMillan, D. J., Batzloff, M. R., Pruksakorn, S., Good, M. F., & Sriprakash, K. S. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.079 · Cited by 25
Self-citationSharma, A., Arya, D. K., Sagar, V., Bergmann, R., Chhatwal, G. S., & Johri, A. K. (2012) · Journal of Proteome Research · doi:10.1021/pr3005265 · Cited by 25 · cited 1×
“For instance, one study coupled high-throughput multigenome data mining with proteomics to identify 52 potentially universal GAS vaccine candidates (586), which are yet to be tested in in vivo studies.”
BackgroundPires, R., Rolo, D., Gama-Norton, L., Morais, A., Lito, L., Salgado, M. J., JOHANSSON, C., Möllerberg, G., Henriques‐Normark, B., Marques, J. G., et al. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.360 · Cited by 25
Koh, E., & Kim, S. (2010) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2010.30.5.485 · Cited by 25 · cited 2×
“6% in 2009; however, in this case, the decrease was more likely due to a reduction in the prevalence of a resistant emm 12 GAS clone rather than a decrease in macrolide usage (496).”
BackgroundGroup A Streptococcal Necrotizing Fasciitis in the Emergency Department
Lin, J., Chang, L., Lai, C., Lin, H.-H., & Chen, Y. (2013) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2013.05.046 · Cited by 25
de Oliveira, S. K. F. (2007) · Jornal de Pediatria · doi:10.2223/jped.1615 · Cited by 24
An outbreak of group a food-borne streptococcal pharyngitis
Gallo, G., Berzero, R., Cattai, N., Recchia, S., & Orefici, G. (1992) · European Journal of Epidemiology · doi:10.1007/bf00144817 · Cited by 24
Bacterial Adherence of Group A Streptococci to Mucosal Surfaces
Beachey, E. H., & Courtney, H. S. (2009) · Respiration · doi:10.1159/000195749 · Cited by 24
Pichichero, M. E., & Casey, J. R. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.04.010 · Cited by 24 · cited 1×
“Several antimicrobial agents, including clarithromycin, cefuroxime, and cefixime, can successfully eradicate GAS from the pharynx when administered for 5 days (446, 447), and effective eradication with once-daily dosing has been described for amoxicillin, azithromycin, and various cephalosporins (448, 449).”
BackgroundUlrich, R. G. (2008) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-6-8 · Cited by 23
Gillen, C. M., Towers, R. J., McMillan, D. J., Delvecchio, A., Sriprakash, K. S., Currie, B. J., Kreikemeyer, B., Chhatwal, G. S., & Walker, M. J. (2002) · Microbiology · doi:10.1099/00221287-148-1-169 · Cited by 23 · cited 1×
“A number of obstacles hinder the development of a GAS vaccine, including serotype diversity (528), antigenic variation (529), pronounced differences in the geographical distribution of serotypes (4), and, critically, the potential for GAS antigens to produce imGroup A Streptococcus Disease and Pathogenesis”
BackgroundSelf-citationHeirstraeten, L. V., Leten, G., Lammens, C., Goossens, H., & Malhotra‐Kumar, S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks281 · Cited by 23
Ofek, I., Bergner-Rabinowitz, S., & Ginsburg, I. (1970) · The Journal of Infectious Diseases · doi:10.1093/infdis/122.6.517 · Cited by 23 · cited 1×
“SLS contributes to GAS virulence and pathogenesis by lysing a broad spectrum of host cells, including lymphocytes, erythrocytes, platelets, and several other cells (232).”
BackgroundChemical properties and immunobiological activities of streptococcal lipoteichoic acids
Hamada, S., Yamamoto, T., Koga, T., McGhee, J. R., Michalek, S. M., & Yamamoto, S. (1985) · Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology · doi:10.1016/s0176-6724(85)80054-7 · Cited by 22 · cited 1×
“LTA, a membrane-bound amphiphilic polymer of glycerol phosphate containing glucose and D-alanine substitutes (115), may contribute to the initial adherence of GAS to host surfaces by establishing weak hydrophobic interactions between bacterial cells and host components (114).”
BackgroundEffect of lipoteichoic acid on the uptake of Streptococcus pyogenes by HEp-2 cells
Sela, S., Marouni, M. J., Perry, R., & Barzilai, A. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09422.x · Cited by 22
Påhlman, L. I., Malmström, E., Mörgelin, M., & Herwald, H. (2007) · Microbiology · doi:10.1099/mic.0.2006/003285-0 · Cited by 22 · cited 1×
“Serotype-dependent activation of the extrinsic pathway of coagulation has been demonstrated in vitro, with heat-killed serotype M1 and M3, but not serotype M6, GAS strains triggering tissue factor synthesis on isolated human monocytes and cultured human umbilical vein endothelial cells, resulting in subsequent inducti…”
BackgroundBinks, M., McMillan, D. J., & Sriprakash, K. S. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.6701-6706.2003 · Cited by 22 · cited 1×
“Variants of SIC, termed CRS (closely related to SIC) and DRS (distantly related to SIC), also bind complement proteins C6 and C7 (216, 217).”
BackgroundSelf-citationFailure to eradicate streptococci and beta‐lactamase producing bacteria
Brook, I., & Gober, A. E. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00610.x · Cited by 21 · cited 1×
“It has been suggested that GAS may escape penicillin treatment by entering epithelial cells, which are poorly penetrated by penicillin (475–477), or by forming a biofilm (478, 479), or alternatively, failure of penicillin treatment may possibly be due to the protection of GAS by other -lactamase-producing bacterial sp…”
BackgroundAntimicrobial susceptibility of select respiratory tract pathogens in Dakar, Senegal
Ndiaye, A., Boye, C. S., Edwige, H., Guèye, F. B., & Badiane, A. S. (2009) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.20 · Cited by 21
Zheng, M.-H., Jiao, Z.-Q., Zhang, L., Yu, S., Tang, G., Yan, X., He, L., Meng, F., Zhao, F., Zhang, M.-J., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00747-08 · Cited by 21
DeMaster, E., Schnitzler, N., Cheng, Q., & Cleary, P. P. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.350-359.2002 · Cited by 21 · cited 1×
“tem involved in neutrophil recruitment and stimulation (273).”
BackgroundCole, J. N., Aziz, R. K., Kuipers, K., Timmer, A. M., Nizet, V., & van Sorge, N. M. (2012) · Journal of Bacteriology · doi:10.1128/jb.01317-12 · Cited by 21 · cited 1×
“In serotype M1T1 GAS strains, the second gene in the operon, hasB, is nonessential due to the presence of HasB2, a secondary UDP-glucose 6-dehydrogenase encoded by hasB2 that is located outside hasABC (199).”
BackgroundSelf-citationBryant, A. E., Hayes‐Schroer, S. M., & Stevens, D. L. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1903-1910.2003 · Cited by 21 · cited 2×
“However, vascular thrombosis can promote hypoxia-induced tissue damage in necrotizing fasciitis (373).”
Background[Growth-coupled lipid synthesis in Mortierella alpina LPM 301, a producer of arachidonic acid].
Ерошин, В. К., Dediukhina, E. G., Satrutdinov, A. D., & Chistyakova, T. I. (2002) · PubMed · Cited by 20
Kasper, K. J., Wang, X., Rahman, A., Nooh, M. M., Kotb, M., Sundberg, E. J., Madrenas, J., & McCormick, J. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3384 · Cited by 20 · cited 1×
“The result is a massive cytokine response by T cells (lymphotoxin- , IL-2, and IFN- ) and antigen-presenting cells (TNF- , IL-1 , and IL-6), which causes widespread tissue damage, disseminated intravascular thrombosis, and organ dysfunction (7, 81, 291, 292).”
BackgroundNephritis-Associated Streptococcal Antigens
Rodríguez‐Iturbe, B. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133012.53669.1c · Cited by 20 · cited 1×
“Such a mechanism has been proposed (422, 423).”
BackgroundStreptococcal diseases worldwide: present status and prospects.
Rotta, J., & Tikhomirov, E. (1987) · PubMed · Cited by 20
Nitzan, D., Barak, E., Kaufman, Z., Valinsky, L., Marva, E., Korenman, Z., Gorodnitzky, Z., Yishai, R., Koltai, D., Leventhal, A., et al. (2006) · PubMed · Cited by 19
A food-borne streptococcal sore throat outbreak in a small community
Asteberg, I., Andersson, Y., Dotevall, L., Ericsson, M., Darenberg, J., Henriques-Nordmark, B., & Söderström, A. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600868370 · Cited by 18
Activating effect of the plasminogen activators on plasminogens of different mammalia species
Yakovlev, S., Рубленко, М. В., Izdepsky, V. I., & Em, M. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00131-a · Cited by 18 · cited 1×
“The species specificity of Ska impacts the design and utility of small-animal models of GAS infection (334).”
BackgroundNir‐Paz, R., Korenman, Z., Ron, M., Michael-Gayego, A., Cohen‐Poradosu, R., Valinsky, L., Beall, B., & Moses, A. E. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809002805 · Cited by 18
Goodfellow, A. M., Hoy, W. E., Sriprakash, K. S., Daly, M. J., Reeve, M. P., & Mathews, J. D. (1999) · Epidemiology and Infection · doi:10.1017/s0950268898001812 · Cited by 18 · cited 1×
“In the indigenous Australian population, the mean age of onset of overt albuminurea for GAS-seropositive patients is 15 to 30 years earlier than that for GAS-seronegative patients (428), suggesting that past GAS infection is a risk factor for chronic kidney disease in this population.”
BackgroundSelf-citationIncorporation of d -Alanine into the Membrane of Streptococcus pyogenes and Its Stabilized L-Form
Chevion, M., Panos, C., Linzer, R., & Neuhaus, F. C. (1974) · Journal of Bacteriology · doi:10.1128/jb.120.3.1026-1032.1974 · Cited by 17 · cited 5×
“The D-alanine–D-alanyl carrier protein ligase, DltA, is required for D-alanylation of lipoteichoic acid (LTA) (260), a surface-bound amphiphilic polyglycerolphosphate polymer important for GAS epithelial cell adherence (261, 262).”
BackgroundInfluentialMa, C., Li, C., Wang, X.-R., Zeng, R., Yin, X.-L., Feng, H., & Wei, L. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.10 · Cited by 17 · cited 1×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundPavia, D., Lopez-Vidriero, M. T., Agnew, J. E., Taylor, R. G., Eyre-Brook, A. L., Lawton, W. A., Pellow, P. G. D., & Clarke, S. W. (2009) · Respiration · doi:10.1159/000195703 · Cited by 17
Georgousakis, M., Hofmann, A., Batzloff, M. R., McMillan, D. J., & Sriprakash, K. S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.049 · Cited by 16
Self-citationWiddowson, J. P., Maxted, W. R., Newrick, C. W., & Parkin, D. M. (1974) · Journal of Hygiene · doi:10.1017/s0022172400023135 · Cited by 16 · cited 42×
“In a 2005 study, the highest rates of ARF were found in sub-Saharan Africa (5.7 cases per 1,000), in the Pacific Islander and indigenous minority populations of Australia and New Zealand (3.5 cases per 1,000), and south central Asia (United Nations regional classification) (2.2 cases per 1,000) (5).”
BackgroundInfluentialAcute Rheumatic Fever and Poststreptococcal Reactive Arthritis
Alsaeid, K., & Uziel, Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00044-2 · Cited by 16 · cited 41×
“In a 2005 study, the highest rates of ARF were found in sub-Saharan Africa (5.7 cases per 1,000), in the Pacific Islander and indigenous minority populations of Australia and New Zealand (3.5 cases per 1,000), and south central Asia (United Nations regional classification) (2.2 cases per 1,000) (5).”
BackgroundInfluentialInoue, M., Kohno, S., Kaku, M., Yamaguchi, K., Igari, J., & Yamanaka, K. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.03.008 · Cited by 15
Yan, S. S., Schreckenberger, P. C., Zheng, X., Nelson, N. A., Harrington, S. M., TJHIO, J. T., & Fedorko, D. P. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.04.018 · Cited by 15
Invasive Group A Streptococcal Disease: Management and Chemoprophylaxis
Allen, U., & Moore, D. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/585187 · Cited by 14
Kumar, R., Chakraborti, A., Aggarwal, A. K., Vohra, H., Sagar, V., Dhanda, V., Sharma, Y. P., Majumdar, S., Hoe, N. P., & Rm, K. (2012) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.93437 · Cited by 14
Michaelsen, T. E., Andreasson, I. K. G., Langerud, B. K., & Caugant, D. A. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02594.x · Cited by 13
Chiou, C., Wang, Y.-W., Chen, P.-L., Wang, W., Wu, P.-F., & Wei, H.-L. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-115 · Cited by 13
Detection of nephritis strain-associated streptokinase by monoclonal antibodies
Ohkuni, H., Todome, Y., Yoshimura, K., Yamamoto, T., Suzuki, H., Yokomuro, K., Johnston, K. H., & Zabriskie, J. B. (1991) · Journal of Medical Microbiology · doi:10.1099/00222615-35-1-60 · Cited by 13
Sarvghad, M. R., Naderi, H., Naderi-Nassab, M., Majdzadeh, R., Javanian, M., Faramarzi, H., & Fatehmanesh, P. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510044085 · Cited by 12
Dhanda, V., Vohra, H., & Kumar, R. (2011) · PubMed · Cited by 12
Tsatsaronis, J. A., Hollands, A., Cole, J. N., Maamary, P. G., Gillen, C. M., Zakour, N. L. B., Kotb, M., Nizet, V., Beatson, S. A., Walker, M. J., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-226662 · Cited by 12
Self-citationCarroll, R. K., Beres, S. B., Sitkiewicz, I., Peterson, L., Matsunami, R., Engler, D., Flores, A. R., Sumby, P., & Musser, J. (2011) · Epidemics · doi:10.1016/j.epidem.2011.07.001 · Cited by 12 · cited 1×
“SpeB expression is strongly downregulated in both covRS mutants (277, 294) and ropB mutants (316, 318).”
BackgroundMasuyama, T., Ishii, E., Muraoka, K., Honjo, S., Yamaguchi, H., Hara, T., SHIMAZAKI, K., Tatsuhiko, K. O. G. A., Moriya, K., Ide, M., et al. (1996) · Pediatrics International · doi:10.1111/j.1442-200x.1996.tb03454.x · Cited by 11
Wozniak, A., Rojas, P. A., RODRÍGUEZ, C., Undabarrena, A., Gárate, C., Ingrid Riedel, K., Román, J. C. B., Kalergis, A. M., & García, P. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811001889 · Cited by 11
Research works printed but not linked: 3
- Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470–511. 10.1128/CMR.13.3.470-511.2000 [DOI] [PMC free article] [PubMed] [Google Scholar] · doi:10.1128/cmr.13.3.470-511.2000 · Paper page
- WHO. 2005. The current evidence for the burden of group A streptococcal diseases. WHO report. WHO, Geneva, Switzerland [Google Scholar]
- American Academy of Pediatrics. 2012. Group A streptococcal infections, p 668–680 In Pickering LK, Baker CJ, Kimberlin DW, Long SS. (ed), Red book: 2012 report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL [Google Scholar]
Cited by
The wound microbiota: microbial mechanisms of impaired wound healing and infection
Uberoi, A., McCready-Vangi, A., & Grice, E. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01035-z · Cited by 864
“Interestingly, most adhesin proteins are not present universally across all GAS strains and it is thought that expression and/or regulation of adhesins plays a role in determining tissue tropism of GAS bacteria 79 .”
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
Pathogenesis, epidemiology and control of Group A Streptococcus infection
Brouwer, S., Rivera-Hernandez, T., Curren, B. F., Harbison-Price, N., De Oliveira, D. M. P., Jespersen, M. G., Davies, M. R., & Walker, M. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00865-7 · Cited by 374
Self-citationEmerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Nii-Trebi, N. I. (2017) · BioMed Research International · doi:10.1155/2017/5245021 · Cited by 356
“By understanding the dynamics of disease and the means of contracting it, methods of fighting, preventing, and controlling are developed [2, 5, 6].”
Lawrence, J. G., Carapetis, J. R., Griffiths, K., Edwards, K., & Condon, J. R. (2013) · Circulation · doi:10.1161/circulationaha.113.001477 · Cited by 282
Metadata
- Authors
- Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V.
- Affiliations
- The University of Queensland (AU)
- University of Wollongong (AU)
- QIMR Berghofer Medical Research Institute (AU)
- School of Biological Sciences and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia
- University of California San Diego (US)
- Corresponding author
- Walker, Mark J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2014-04
- Volume
- 27
- Issue
- 2
- Pages
- 264-301
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC3993104
- OpenAlex
- W2145736155
- Cited by
- 908
- References
- 626
- Citations by year
- 2026: 74 · 2025: 85 · 2024: 96 · 2023: 81 · 2022: 82 · 2021: 87 · 2020: 91 · 2019: 76 · 2018: 57 · 2017: 59 · 2016: 55 · 2015: 50 · 2014: 12
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI077780)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052728)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Keywords
- Streptococcus pyogenes, virulence factors, pathogenesis, pharyngitis, impetigo, necrotizing fasciitis, toxic shock syndrome, post-streptococcal glomerulonephritis, rheumatic fever, rheumatic heart disease, innate immune evasion, tissue degradation, antibiotic resistance, streptococcal vaccine, disease progression model
- MeSH terms
- Animals, Anti-Bacterial Agents, Disease Models, Animal, Humans, Streptococcal Infections, Streptococcus pyogenes, Virulence, Streptococcal Vaccines, Drug Resistance, Bacterial, Virulence Factors, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.